# Therapair Shareholder Agreement Template

## ðŸ“‹ Document Overview

**Entity:** Therapair Pty Ltd  
**Parties:** Prequel (65%) | Unison Mental Health (35%)  
**Purpose:** Define rights, responsibilities, and governance structure  
**Effective Date:** [DATE]  
**Version:** 1.0

---

## 1. DEFINITIONS

### **1.1 Key Terms**
- **"Company"** means Therapair Pty Ltd (ACN: [TO BE ASSIGNED])
- **"Prequel"** means Prequel Pty Ltd (ACN: [TO BE ASSIGNED])
- **"Unison"** means Unison Mental Health Pty Ltd (ACN: [TO BE ASSIGNED])
- **"Board"** means the board of directors of the Company
- **"Shares"** means ordinary shares in the Company
- **"Majority Shareholder"** means Prequel (65% ownership)
- **"Minority Shareholder"** means Unison (35% ownership)

### **1.2 Business Purpose**
The Company's primary business is the development, operation, and commercialization of an AI-powered therapist matching platform and related mental health technology services.

---

## 2. SHAREHOLDING STRUCTURE

### **2.1 Initial Shareholding**
- **Prequel:** 65% (6,500 shares)
- **Unison Mental Health:** 35% (3,500 shares)
- **Total Issued Shares:** 10,000 shares

### **2.2 Share Classes**
- **Ordinary Shares:** Voting and dividend rights
- **Employee Option Pool:** 10-15% reserved for future employee incentives
- **Future Investor Shares:** To be issued in future funding rounds

### **2.3 Transfer Restrictions**
- **Right of First Refusal:** Existing shareholders have first right to purchase
- **Tag-Along Rights:** Minority can sell with majority
- **Drag-Along Rights:** Majority can force minority to sell (with protections)
- **Pre-emptive Rights:** Right to participate in new share issues

---

## 3. GOVERNANCE STRUCTURE

### **3.1 Board of Directors**
- **Total Board Size:** 5 directors
- **Prequel Appointees:** 3 directors (including Chair)
- **Unison Appointees:** 2 directors
- **Independent Directors:** 1 (mutually agreed, non-executive)

### **3.2 Board Meetings**
- **Frequency:** Quarterly (minimum)
- **Notice:** 14 days written notice
- **Quorum:** 3 directors (including at least 1 from each party)
- **Voting:** Simple majority (except reserved matters)

### **3.3 Reserved Matters (Require 75% Approval)**
- **Major Strategic Decisions:** Business model changes, market expansion
- **Financial Decisions:** Annual budget, major capital expenditure (>$100K)
- **Legal Decisions:** Litigation, regulatory compliance, IP strategy
- **Partnership Decisions:** Major partnerships, joint ventures, acquisitions
- **Exit Decisions:** Sale of company, merger, dissolution

### **3.4 Unison Veto Rights (Clinical/Ethical)**
- **Clinical Standards:** Changes to clinical protocols or standards
- **Practitioner Verification:** Changes to practitioner verification process
- **User Safety:** Changes affecting user safety or clinical outcomes
- **Ethical Guidelines:** Changes to ethical guidelines or policies
- **Mental Health Compliance:** Changes to mental health regulatory compliance

---

## 4. MANAGEMENT & OPERATIONS

### **4.1 Executive Management**
- **CEO:** Appointed by Prequel (with Unison consultation)
- **CTO:** Appointed by Prequel
- **Clinical Director:** Appointed by Unison
- **CFO:** Appointed by mutual agreement

### **4.2 Day-to-Day Operations**
- **Prequel Responsibilities:**
  - Product development and technology
  - Sales and marketing
  - Business development and partnerships
  - Financial management and fundraising
  - Legal and regulatory compliance

- **Unison Responsibilities:**
  - Clinical oversight and quality assurance
  - Practitioner relationships and verification
  - Mental health industry relationships
  - Clinical training and education
  - Ethical and safety standards

### **4.3 Decision-Making Authority**
- **Operational Decisions:** CEO authority (within approved budget)
- **Strategic Decisions:** Board approval required
- **Clinical Decisions:** Clinical Director authority (with Board oversight)
- **Financial Decisions:** CFO authority (within approved limits)

---

## 5. FINANCIAL MATTERS

### **5.1 Capital Contributions**
- **Initial Capital:** As agreed in separate capital contribution agreement
- **Additional Capital:** Pro rata contributions or dilution
- **Funding Rounds:** Both parties participate pro rata or face dilution

### **5.2 Profit Distribution**
- **Dividend Policy:** Board discretion (considering growth needs)
- **Distribution Rights:** Proportional to shareholding
- **Retained Earnings:** Reinvestment in business growth
- **Reserve Fund:** Maintain 6-month operating expenses

### **5.3 Financial Reporting**
- **Monthly Reports:** Management accounts to Board
- **Quarterly Reports:** Detailed financial statements
- **Annual Reports:** Audited financial statements
- **Ad Hoc Reports:** As requested by Board

---

## 6. INTELLECTUAL PROPERTY

### **6.1 IP Ownership**
- **Company IP:** All IP developed for Company business
- **Background IP:** Retained by respective parties
- **Joint IP:** Shared ownership with Company having commercial rights
- **Third-Party IP:** Licensed to Company for business use

### **6.2 IP Protection**
- **Patent Strategy:** Company files and maintains patents
- **Trademark Strategy:** Company registers and maintains trademarks
- **Copyright Protection:** Company protects software and content
- **Trade Secret Protection:** Confidentiality agreements required

### **6.3 IP Licensing**
- **Company Use:** IP licensed to Company for business purposes
- **Third-Party Licensing:** Board approval required
- **Cross-Licensing:** Between shareholders as needed
- **IP Valuation:** Independent valuation for major transactions

---

## 7. COMPETITION & NON-COMPETE

### **7.1 Non-Compete Obligations**
- **Scope:** Mental health technology and matching services
- **Duration:** 2 years post-exit
- **Geographic:** Australia and target international markets
- **Exceptions:** Passive investments, unrelated businesses

### **7.2 Confidentiality**
- **Confidential Information:** All business and technical information
- **Duration:** Perpetual (even after exit)
- **Use Restrictions:** Only for Company business purposes
- **Return Obligations:** Return all confidential information on exit

### **7.3 Non-Solicitation**
- **Employees:** Cannot solicit Company employees for 1 year
- **Customers:** Cannot solicit Company customers for 2 years
- **Partners:** Cannot solicit Company partners for 1 year
- **Exceptions:** General advertising, unsolicited approaches

---

## 8. EXIT PROVISIONS

### **8.1 Voluntary Exit**
- **Notice Period:** 12 months written notice
- **Valuation Process:** Independent business valuation
- **Purchase Rights:** Other party has right to purchase
- **Payment Terms:** 50% cash, 50% over 2 years

### **8.2 Involuntary Exit**
- **Breach of Agreement:** Material breach not cured within 30 days
- **Insolvency:** Bankruptcy or insolvency of shareholder
- **Death/Disability:** Death or permanent disability of key person
- **Regulatory Issues:** Loss of required licenses or permits

### **8.3 Drag-Along Rights**
- **Trigger:** 75% shareholder approval for sale
- **Notice:** 60 days written notice
- **Terms:** Same terms and conditions for all shareholders
- **Protections:** Minimum price, payment terms, indemnification

### **8.4 Tag-Along Rights**
- **Trigger:** Majority shareholder selling shares
- **Notice:** 30 days written notice
- **Participation:** Minority can participate in sale
- **Terms:** Same terms and conditions as majority

---

## 9. DISPUTE RESOLUTION

### **9.1 Dispute Resolution Process**
1. **Direct Negotiation:** 30 days good faith negotiation
2. **Mediation:** 60 days mediation with agreed mediator
3. **Arbitration:** Binding arbitration under Australian Arbitration Act
4. **Litigation:** Court proceedings as last resort

### **9.2 Governing Law**
- **Jurisdiction:** Victoria, Australia
- **Governing Law:** Australian law
- **Courts:** Victorian courts have jurisdiction
- **Language:** English language for all proceedings

---

## 10. GENERAL PROVISIONS

### **10.1 Entire Agreement**
This agreement constitutes the entire agreement between the parties and supersedes all prior negotiations, representations, or agreements.

### **10.2 Amendment**
This agreement may only be amended by written agreement signed by all parties.

### **10.3 Severability**
If any provision is held invalid or unenforceable, the remaining provisions shall remain in full force and effect.

### **10.4 Assignment**
This agreement may not be assigned without written consent of all parties.

### **10.5 Notices**
All notices must be in writing and delivered to the registered office of each party.

---

## 11. SIGNATURES

**Prequel Pty Ltd**  
Signature: _________________________  
Name: [AUTHORIZED REPRESENTATIVE]  
Title: [TITLE]  
Date: _________________________

**Unison Mental Health Pty Ltd**  
Signature: _________________________  
Name: [AUTHORIZED REPRESENTATIVE]  
Title: [TITLE]  
Date: _________________________

**Therapair Pty Ltd**  
Signature: _________________________  
Name: [AUTHORIZED REPRESENTATIVE]  
Title: [TITLE]  
Date: _________________________

---

**Document Version:** 1.0  
**Last Updated:** October 28, 2025  
**Legal Review Required:** Yes  
**Next Review:** November 28, 2025
